Australian Biotech Firm Vaxxas Secures $90 Million Funding for Revolutionary Vaccine Technology
Vaxxas, an Australian biotech company, has raised $90 million in funding to advance its innovative…
Vaxxas, an Australian biotech company, has raised $90 million in funding to advance its innovative…
A recent trend in the US job market reveals that Gen Z men are falling…
A new healthcare facility is set to open in Alabama, offering a range of medical…
Mitsubishi is nearing an investment deal with Fullerton Health, a leading Singapore-based healthcare provider, to…
A veteran doctor shares fond memories of Homestead Hospital, highlighting its rich history and impact…
Colorado lawmakers introduce bills to protect SNAP benefits and Planned Parenthood services from federal funding…
A surge in violent attacks on hospital workers has prompted liberals to speak out against…
The Medicare Act's administrative exhaustion requirement has been a topic of discussion in recent court…
A woman's 10-year undiagnosed illness was finally solved when contractors fixing her bathroom discovered the…
Rep. Vindman denounces federal cuts and DEI rollbacks, sparking concerns at Northern Virginia Black Chamber…